|
1
|
Postma AV, Bezzina CR and Christoffels VM:
Genetics of congenital heart disease: The contribution of the
noncoding regulatory genome. J Hum Genet. 61:13–19. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Writing Group Members, . Mozaffarian D,
Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de
Ferranti S, Després JP, et al: Heart Disease and Stroke
Statistics-2016 Update: A Report From the American Heart
Association. Circulation. 133:e38–e360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van der Linde D, Konings EE, Slager MA,
Witsenburg M, Helbing WA, Takkenberg JJ and Roos-Hesselink JW:
Birth prevalence of congenital heart disease worldwide: A
systematic review and meta-analysis. J Am Coll Cardiol.
58:2241–2247. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhu H: Forkhead box transcription factors
in embryonic heart development and congenital heart disease. Life
Sci. 144:194–201. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bruneau BG: The developmental genetics of
congenital heart disease. Nature. 451:943–948. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fahed AC, Gelb BD, Seidman JG and Seidman
CE: Genetics of congenital heart disease: The glass half empty.
Circ Res. 112:707–720. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Andersen TA, Troelsen Kde L and Larsen LA:
Of mice and men: Molecular genetics of congenital heart disease.
Cell Mol Life Sci. 71:1327–1352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lalani SR and Belmont JW: Genetic basis of
congenital cardiovascular malformations. Eur J Med Genet.
57:402–413. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Patel SS and Burns TL: Nongenetic risk
factors and congenital heart defects. Pediatr Cardiol.
34:1535–1555. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zaidi S, Choi M, Wakimoto H, Ma L, Jiang
J, Overton JD, Romano-Adesman A, Bjornson RD, Breitbart RE, Brown
KK, et al: De novo mutations in histone-modifying genes in
congenital heart disease. Nature. 498:220–223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Al Turki S, Manickaraj AK, Mercer CL,
Gerety SS, Hitz MP, Lindsay S, D'Alessandro LC, Swaminathan GJ,
Bentham J, Arndt AK, et al: Rare variants in NR2F2 cause congenital
heart defects in humans. Am J Hum Genet. 94:574–585. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Werner P, Paluru P, Simpson AM, Latney B,
Iyer R, Brodeur GM and Goldmuntz E: Mutations in NTRK3 suggest a
novel signaling pathway in human congenital heart disease. Hum
Mutat. 35:1459–1468. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiang R, Fan LL, Huang H, Cao BB, Li XP,
Peng DQ and Xia K: A novel mutation of GATA4 (K319E) is responsible
for familial atrial septal defect and pulmonary valve stenosis.
Gene. 534:320–323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi LM, Tao JW, Qiu XB, Wang J, Yuan F, Xu
L, Liu H, Li RG, Xu YJ, Wang Q, et al: GATA5 loss-of-function
mutations associated with congenital bicuspid aortic valve. Int J
Mol Med. 33:1219–1226. 2014.PubMed/NCBI
|
|
15
|
Huang RT, Xue S, Xu YJ, Zhou M and Yang
YQ: Somatic GATA5 mutations in sporadic tetralogy of Fallot. Int J
Mol Med. 33:1227–1235. 2014.PubMed/NCBI
|
|
16
|
Wang X, Ji W, Wang J, Zhao P, Guo Y, Xu R,
Chen S and Sun K: Identification of two novel GATA6 mutations in
patients with nonsyndromic conotruncal heart defects. Mol Med Rep.
10:743–748. 2014.PubMed/NCBI
|
|
17
|
Zhao L, Ni SH, Liu XY, Wei D, Yuan F, Xu
L, Xin-Li, Li RG, Qu XK, Xu YJ, et al: Prevalence and spectrum of
Nkx2.6 mutations in patients with congenital heart disease. Eur J
Med Genet. 57:579–586. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cowan J, Tariq M and Ware SM: Genetic and
functional analyses of ZIC3 variants in congenital heart disease.
Hum Mutat. 35:66–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qu XK, Qiu XB, Yuan F, Wang J, Zhao CM,
Liu XY, Zhang XL, Li RG, Xu YJ, Hou XM, et al: A novel NKX2.5
loss-of-function mutation associated with congenital bicuspid
aortic valve. Am J Cardiol. 114:1891–1895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei D, Gong XH, Qiu G, Wang J and Yang YQ:
Novel PITX2c loss-of-function mutations associated with complex
congenital heart disease. Int J Mol Med. 33:1201–1208.
2014.PubMed/NCBI
|
|
21
|
Homsy J, Zaidi S, Shen Y, Ware JS, Samocha
KE, Karczewski KJ, DePalma SR, McKean D, Wakimoto H, Gorham J, et
al: De novo mutations in congenital heart disease with
neurodevelopmental and other congenital anomalies. Science.
350:1262–1266. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Klena NT, Gabriel GC, Liu X, Kim AJ,
Lemke K, Chen Y, Chatterjee B, Devine W, Damerla RR, et al: Global
genetic analysis in mice unveils central role for cilia in
congenital heart disease. Nature. 521:520–524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guimier A, Gabriel GC, Bajolle F, Tsang M,
Liu H, Noll A, Schwartz M, El Malti R, Smith LD, Klena NT, et al:
MMP21 is mutated in human heterotaxy and is required for normal
left-right asymmetry in vertebrates. Nat Genet. 47:1260–1263. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pan Y, Geng R, Zhou N, Zheng GF, Zhao H,
Wang J, Zhao CM, Qiu XB, Yang YQ and Liu XY: TBX20 loss-of-function
mutation contributes to double outlet right ventricle. Int J Mol
Med. 35:1058–1066. 2015.PubMed/NCBI
|
|
25
|
Li X, Wang G, An Y, Li H, Li Y and Wu C:
Association between sequence variations in RCAN1 promoter and the
risk of sporadic congenital heart disease in a Chinese population.
Pediatr Cardiol. 36:1393–1399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang J, Zhu M, Wang Y, Hou X, Wu H, Wang
D, Shen H, Hu Z and Zou J: Whole-exome sequencing identify a new
mutation of MYH7 in a Chinese family with left ventricular
noncompaction. Gene. 58:138–142. 2015. View Article : Google Scholar
|
|
27
|
Zheng J, Li F, Liu J, Xu Z, Zhang H, Fu Q,
Wang J and Sun K: Investigation of somatic NKX2-5 mutations in
Chinese children with congenital heart disease. Int J Med Sci.
12:538–543. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang J, Mao JH, Ding KK, Xu WJ, Liu XY,
Qiu XB, Li RG, Qu XK, Xu YJ, Huang RT, et al: A novel NKX2.6
mutation associated with congenital ventricular septal defect.
Pediatr Cardiol. 36:646–656. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pan Y, Wang ZG, Liu XY, Zhao H, Zhou N,
Zheng GF, Qiu XB, Li RG, Yuan F, Shi HY, et al: A novel TBX1
loss-of-function mutation associated with congenital heart disease.
Pediatr Cardiol. 36:1400–1410. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun YM, Wang J, Qiu XB, Yuan F, Xu YJ, Li
RG, Qu XK, Huang RT, Xue S and Yang YQ: PITX2 loss-of-function
mutation contributes to tetralogy of Fallot. Gene. 577:258–264.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu CX, Gong HR, Liu XY, Wang J, Zhao CM,
Huang RT, Xue S and Yang YQ: A novel HAND2 loss-of-function
mutation responsible for tetralogy of Fallot. Int J Mol Med.
37:445–451. 2016.PubMed/NCBI
|
|
32
|
Cao Y, Wang J, Wei C, Hou Z, Li Y, Zou H,
Meng M, Wang W and Jiang L: Genetic variations of NKX2-5 in
sporadic atrial septal defect and ventricular septal defect in
Chinese Yunnan population. Gene. 575:29–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen J, Qi B, Zhao J, Liu W, Duan R and
Zhang M: A novel mutation of GATA4 (K300T) associated with familial
atrial septal defect. Gene. 575:473–477. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yoshida A, Morisaki H, Nakaji M, Kitano M,
Kim KS, Sagawa K, Ishikawa S, Satokata I, Mitani Y, Kato H, et al:
Genetic mutation analysis in Japanese patients with non-syndromic
congenital heart disease. J Hum Genet. 61:157–162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun YM, Wang J, Qiu XB, Yuan F, Li RG, Xu
YJ, Qu XK, Shi HY, Hou XM, Huang RT, et al: A HAND2
loss-of-function mutation causes familial ventricular septal defect
and pulmonary stenosis. G3 (Bethesda). 6:987–992. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
McCulley DJ and Black BL: Transcription
factor pathways and congenital heart disease. Curr Top Dev Biol.
100:253–277. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Saga Y, Kitajima S and Miyagawa-Tomita S:
Mesp1 expression is the earliest sign of cardiovascular
development. Trends Cardiovasc Med. 10:345–352. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bondue A and Blanpain C: Mesp1: A key
regulator of cardiovascular lineage commitment. Circ Res.
107:1414–1427. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Saga Y: Genetic rescue of segmentation
defect in MesP2-deficient mice by MesP1 gene replacement. Mech Dev.
75:53–66. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Saga Y, Miyagawa-Tomita S, Takagi A,
Kitajima S, Miyazaki JI and Inoue T: MesP1 is expressed in the
heart precursor cells and required for the formation of a single
heart tube. Development. 126:3437–3447. 1999.PubMed/NCBI
|
|
41
|
Werner P, Latney B, Deardorff MA and
Goldmuntz E: MESP1 mutations in patients with congenital heart
defects. Hum Mutat. 37:308–314. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Schott JJ, Benson DW, Basson CT, Pease W,
Silberbach GM, Moak JP, Maron BJ, Seidman CE and Seidman JG:
Congenital heart disease caused by mutations in the transcription
factor NKX2-5. Science. 281:108–111. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Garg V, Kathiriya IS, Barnes R,
Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS,
Hirayama-Yamada K, Joo K, et al: GATA4 mutations cause human
congenital heart defects and reveal an interaction with TBX5.
Nature. 424:443–447. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kirk EP, Sunde M, Costa MW, Rankin SA,
Wolstein O, Castro ML, Butler TL, Hyun C, Guo G, Otway R, et al:
Mutations in cardiac T-box factor gene TBX20 are associated with
diverse cardiac pathologies, including defects of septation and
valvulogenesis and cardiomyopathy. Am J Hum Genet. 81:280–291.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lahm H, Deutsch MA, Dreßen M, Doppler S,
Werner A, Hörer J, Cleuziou J, Schreiber C, Böhm J, Laugwitz KL, et
al: Mutational analysis of the human MESP1 gene in patients with
congenital heart disease reveals a highly variable sequence in exon
1. Eur J Med Genet. 56:591–598. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang XH, Huang CX, Wang Q, Li RG, Xu YJ,
Liu X, Fang WY and Yang YQ: A novel GATA5 loss-of-function mutation
underlies lone atrial fibrillation. Int J Mol Med. 31:43–50.
2013.PubMed/NCBI
|
|
47
|
David R, Brenner C, Stieber J, Schwarz F,
Brunner S, Vollmer M, Mentele E, Müller-Höcker J, Kitajima S,
Lickert H, et al: MesP1 drives vertebrate cardiovascular
differentiation through Dkk-1-mediated blockade of Wnt-signalling.
Nat Cell Biol. 10:338–345. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shi X, Zirbes KM, Rasmussen TL, Ferdous A,
Garry MG, Koyano-Nakagawa N and Garry DJ: The transcription factor
Mesp1 interacts with cAMP-responsive element binding protein 1
(Creb1) and coactivates Ets variant 2 (Etv2) gene expression. J
Biol Chem. 290:9614–9625. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lyons I, Parsons LM, Hartley L, Li R,
Andrews JE, Robb L and Harvey RP: Myogenic and morphogenetic
defects in the heart tubes of murine embryos lacking the homeo box
gene Nkx2-5. Genes Dev. 9:1654–1666. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Terada R, Warren S, Lu JT, Chien KR,
Wessels A and Kasahara H: Ablation of Nkx2-5 at mid-embryonic stage
results in premature lethality and cardiac malformation. Cardiovasc
Res. 91:289–299. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Furtado MB, Wilmanns JC, Chandran A, Tonta
M, Biben C, Eichenlaub M, Coleman HA, Berger S, Bouveret R, Singh
R, et al: A novel conditional mouse model for Nkx2-5 reveals
transcriptional regulation of cardiac ion channels.
Differentiation. 91:29–41. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Molkentin JD, Lin Q, Duncan SA and Olson
EN: Requirement of the transcription factor GATA4 for heart tube
formation and ventral morphogenesis. Genes Dev. 11:1061–1072. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kuo CT, Morrisey EE, Anandappa R, Sigrist
K, Lu MM, Parmacek MS, Soudais C and Leiden JM: GATA4 transcription
factor is required for ventral morphogenesis and heart tube
formation. Genes Dev. 11:1048–1060. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Singh MK, Christoffels VM, Dias JM, Trowe
MO, Petry M, Schuster-Gossler K, Bürger A, Ericson J and Kispert A:
Tbx20 is essential for cardiac chamber differentiation and
repression of Tbx2. Development. 132:2697–2707. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Srivastava D, Thomas T, Lin Q, Kirby ML,
Brown D and Olson EN: Regulation of cardiac mesodermal and neural
crest development by the bHLH transcription factor, dHAND. Nat
Genet. 16:154–160. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yamagishi H, Olson EN and Srivastava D:
The basic helix-loop-helix transcription factor, dHAND, is required
for vascular development. J Clin Invest. 105:261–270. 2000.
View Article : Google Scholar : PubMed/NCBI
|
